Indocyanine Green for biliary atresia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Aug 2024: Trial started, NCT07513038
  2. 6 Apr 2026: Trial registered, NCT07513038

The trials

NCT07513038: Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia

State
Under way
Phase
Phase 1 and Phase 2
People
20 planned
Started
1 Aug 2024
Primary completion
Aug 2026
Arms
Indocyanine Green (ICG)
Results
None posted
  1. 1 Aug 2024: Trial started
  2. 6 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Ic-green, IC-Green (ICG), Indocyanine Green (IC-Green), Indocyanine Green (ICG), Indocyanine Green Solution, Spy agent green, Zyogreen.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.